membre depuis:
Portefeuille démarré:
Dernière connexion:
13-04-09
14-04-09
26-05-24 00:00
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
29/01/19 | ADVICENNE | Achat | 900 E | 10.75 | 2.48 | -77.05% | -693 | 26 | |
02/01/19 | ADVICENNE | Achat | 700 E | 9.55 | 2.48 | -74.16% | -519 | 21 | |
02/01/19 | ADVICENNE | Achat | 700 E | 9.55 | 2.48 | -74.16% | -519 | 15 | |
02/01/19 | ADVICENNE | Achat | 750 E | 9.55 | 2.48 | -74.16% | -556 | 15 | |
24/12/18 | INNATE PHARMA | Achat | 900 E | 6.81 | 2.63 | -61.52% | -554 | 26 | |
17/04/18 | OSE IMMUNOTHERAPEUTICS | Achat | 700 E | 4.34 | 7.79 | 79.21% | 554 | 44 | |
16/04/18 | OSE IMMUNOTHERAPEUTICS | Achat | 1 300 E | 4.34 | 7.79 | 79.21% | 1 030 | 46 | |
08/02/18 | OSE IMMUNOTHERAPEUTICS | Achat | 600 E | 3.60 | 7.79 | 116.07% | 696 | 40 | |
23/11/17 | INNATE PHARMA | Achat | 1 000 E | 4.80 | 2.63 | -45.36% | -454 | 48 | |
23/11/17 | INNATE PHARMA | Achat | 1 000 E | 5.10 | 2.63 | -48.58% | -486 | 45 | |
23/11/17 | INNATE PHARMA | Achat | 1 200 E | 5.25 | 2.63 | -50.05% | -601 | 38 | |
26/10/17 | INNATE PHARMA | Achat | 700 E | 9.18 | 2.63 | -71.48% | -500 | 54 | |
26/10/17 | INNATE PHARMA | Achat | 800 E | 9.46 | 2.63 | -72.33% | -579 | 27 | |
28/09/17 | INNATE PHARMA | Achat | 900 E | 10.16 | 2.63 | -74.24% | -668 | 47 | |
19/09/17 | INNATE PHARMA | Achat | 700 E | 10.40 | 2.63 | -74.84% | -524 | 251 | |
07/09/17 | OSE IMMUNOTHERAPEUTICS | Achat | 800 E | 3.63 | 7.79 | 114.29% | 914 | 56 | |
26/06/17 | OSE IMMUNOTHERAPEUTICS | Achat | 900 E | 4.50 | 7.79 | 72.84% | 656 | 57 | |
16/06/17 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.53 | 7.79 | 19.08% | 95 | 42 | |
16/06/17 | OSE IMMUNOTHERAPEUTICS | Achat | 1 100 E | 6.61 | 7.79 | 17.63% | 194 | 26 | |
15/06/17 | OSE IMMUNOTHERAPEUTICS | Achat | 1 200 E | 6.61 | 7.79 | 17.63% | 212 | 36 | |
13/06/17 | OSE IMMUNOTHERAPEUTICS | Achat | 800 E | 6.73 | 7.79 | 15.53% | 124 | 39 | |
26/05/17 | OSE IMMUNOTHERAPEUTICS | Achat | 600 E | 6.65 | 7.79 | 16.93% | 102 | 33 | |
05/04/17 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.78 | 7.79 | 14.68% | 73 | 41 | |
28/02/17 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.46 | 7.79 | 20.37% | 102 | 56 | |
27/02/17 | OSE IMMUNOTHERAPEUTICS | Achat | 700 E | 6.57 | 7.79 | 18.35% | 128 | 41 | |
12/01/17 | OSE IMMUNOTHERAPEUTICS | Achat | 700 E | 7.26 | 7.79 | 7.09% | 50 | 41 | |
03/01/17 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 7.25 | 7.79 | 7.24% | 36 | 39 | |
30/12/16 | OSE IMMUNOTHERAPEUTICS | Achat | 1 200 E | 7.15 | 7.79 | 8.74% | 105 | 38 | |
30/12/16 | OSE IMMUNOTHERAPEUTICS | Achat | 1 200 E | 7.15 | 7.79 | 8.74% | 105 | 26 | |
30/12/16 | OSE IMMUNOTHERAPEUTICS | Achat | 900 E | 7.15 | 7.79 | 8.74% | 79 | 21 | |
31/10/16 | INNATE PHARMA | Achat | 600 E | 11.00 | 2.63 | -76.21% | -457 | 54 | |
28/10/16 | INNATE PHARMA | Achat | 500 E | 11.08 | 2.63 | -76.39% | -382 | 46 | |
04/04/16 | MAUNA KEA TECHNOLOGIES | Achat | 600 E | 2.24 | 0.41 | -81.81% | -491 | 57 | |
08/05/15 | I2S | Achat | 619 E | 1.57 | 7.75 | 393.04% | 2 433 | 28 | |
18/07/14 | MAUNA KEA TECHNOLOGIES | Achat | 500 E | 6.55 | 0.41 | -93.85% | -469 | 54 | |
07/08/13 | I2S | Achat | 300 E | 1.67 | 7.75 | 363.51% | 1 091 | 123 | |
05/04/13 | MAUNA KEA TECHNOLOGIES | Achat | 250 E | 11.86 | 0.41 | -96.65% | -242 | 159 | |
15/03/13 | MAUNA KEA TECHNOLOGIES | Achat | 400 E | 12.16 | 0.41 | -96.73% | -387 | 72 | |
26/02/13 | MAUNA KEA TECHNOLOGIES | Achat | 450 E | 12.22 | 0.41 | -96.75% | -435 | 44 | |
29/01/13 | MAUNA KEA TECHNOLOGIES | Achat | 450 E | 12.25 | 0.41 | -96.76% | -435 | 83 | |
09/11/12 | IT LINK | Achat | 400 E | 2.04 | 31.80 | 1457.16% | 5 829 | 68 | |
26/08/11 | INNATE PHARMA | Achat | 500 E | 1.47 | 2.63 | 78.35% | 392 | 206 | |
07/06/11 | INNATE PHARMA | Achat | 600 E | 1.26 | 2.63 | 108.11% | 649 | 94 | |
Enregistrements 151 à 165 sur 165 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
02/01/13 | METABOLIC EXPLORER | Achat | 500 E | 6.61 | 2.94 | -55.96% | -280 | 82 | |
02/01/13 | METABOLIC EXPLORER | Achat | 400 E | 6.95 | 2.94 | -58.12% | -232 | 198 | |
21/12/12 | IT LINK | Achat | 750 E | 2.51 | 2.85 | 13.12% | 98 | 219 | |
29/10/12 | BIGBEN INTERACTIVE | Achat | 740 E | 6.66 | 8.54 | 27.77% | 205 | 34 | |
23/10/12 | BIGBEN INTERACTIVE | Achat | 560 E | 6.60 | 8.43 | 27.27% | 153 | 156 | |
09/10/12 | ACTEOS | Achat | 800 E | 1.91 | 2.00 | 4.30% | 34 | 31 | |
18/09/12 | ACTEOS | Achat | 500 E | 1.91 | 1.95 | 1.69% | 8 | 86 | |
10/08/12 | BIGBEN INTERACTIVE | Achat | 700 E | 6.66 | 8.13 | 21.63% | 151 | 95 | |
26/07/12 | MODELABS GROUP | Achat | 700 E | 3.70 | 5.00 | 34.66% | 243 | 139 | |
20/07/12 | MODELABS GROUP | Achat | 600 E | 3.23 | 5.01 | 54.60% | 328 | 120 | |
20/07/12 | AB SCIENCE | Achat | 1 000 E | 9.07 | 10.93 | 20.07% | 201 | 83 | |
20/07/12 | MODELABS GROUP | Achat | 717 E | 3.71 | 5.01 | 34.57% | 248 | 101 | |
04/07/12 | AB SCIENCE | Achat | 500 E | 9.07 | 9.97 | 9.50% | 48 | 62 | |
04/07/12 | CAST SA | Achat | 700 E | 1.87 | 2.40 | 27.89% | 195 | 131 | |
29/03/12 | HYBRIGENICS SA | Achat | 400 E | 1.07 | 1.41 | 31.31% | 125 | 87 | |
29/03/12 | INNATE PHARMA | Achat | 700 E | 1.85 | 2.10 | 13.09% | 92 | 71 | |
16/02/12 | ACTEOS | Achat | 500 E | 2.27 | 2.64 | 15.87% | 79 | 120 | |
31/01/12 | ACTEOS | Achat | 395 E | 2.27 | 2.63 | 15.43% | 61 | 63 | |
26/01/12 | IPSOGEN | Achat | 700 E | 11.10 | 11.73 | 5.26% | 37 | 51 | |
25/01/12 | ONXEO | Achat | 500 E | 4.41 | 4.76 | 7.34% | 37 | 106 | |
19/01/12 | ONXEO | Achat | 400 E | 3.12 | 4.59 | 46.62% | 186 | 73 | |
18/01/12 | ONXEO | Achat | 300 E | 3.22 | 4.33 | 34.00% | 102 | 84 | |
13/01/12 | ONXEO | Achat | 400 E | 3.44 | 4.10 | 18.75% | 75 | 64 | |
13/01/12 | ONXEO | Achat | 400 E | 3.78 | 4.09 | 7.78% | 31 | 250 | |
07/12/11 | CAST SA | Achat | 500 E | 1.51 | 1.89 | 24.72% | 124 | 60 | |
05/12/11 | CAST SA | Achat | 400 E | 1.68 | 1.74 | 3.16% | 13 | 63 | |
21/10/11 | IPSOGEN | Achat | 750 E | 7.50 | 12.90 | 71.46% | 536 | 243 | |
21/10/11 | IPSOGEN | Achat | 720 E | 7.50 | 12.90 | 71.46% | 515 | 84 | |
21/10/11 | IPSOGEN | Achat | 750 E | 7.10 | 12.90 | 81.13% | 608 | 84 | |
25/08/11 | MODELABS GROUP | Achat | 500 E | 0.73 | 4.40 | 501.69% | 2 508 | 93 | |
25/08/11 | MODELABS GROUP | Achat | 1 000 E | 0.73 | 4.40 | 501.69% | 5 017 | 80 | |
18/08/11 | IPSOGEN | Achat | 650 E | 7.12 | 12.79 | 79.08% | 514 | 99 | |
17/08/11 | IPSOGEN | Achat | 550 E | 7.03 | 12.78 | 81.23% | 447 | 84 | |
09/08/11 | IPSOGEN | Achat | 580 E | 7.02 | 12.71 | 80.49% | 467 | 80 | |
20/07/11 | LOGIN PEOPLE | Achat | 400 E | 3.96 | 5.80 | 45.97% | 184 | 131 | |
20/07/11 | LOGIN PEOPLE | Achat | 600 E | 14.00 | 5.80 | -59.00% | -354 | 111 | |
19/07/11 | I2S | Achat | 360 E | 2.40 | 4.49 | 86.22% | 310 | 309 | |
12/07/11 | ACTEOS | Achat | 500 E | 1.56 | 2.79 | 78.43% | 392 | 77 | |
12/07/11 | ACTEOS | Achat | 500 E | 1.60 | 2.79 | 73.96% | 370 | 76 | |
07/07/11 | INNATE PHARMA | Achat | 400 E | 1.66 | 2.30 | 38.08% | 152 | 138 | |
21/06/11 | ACTEOS | Achat | 400 E | 2.25 | 2.90 | 28.43% | 114 | 251 | |
21/06/11 | ACTEOS | Achat | 500 E | 2.20 | 2.90 | 31.35% | 157 | 156 | |
21/04/11 | NICOX SA | Achat | 300 E | 5.53 | 1.87 | -66.59% | -200 | 76 | |
21/04/11 | NICOX SA | Achat | 300 E | 5.52 | 1.87 | -66.52% | -200 | 79 | |
21/04/11 | NICOX SA | Achat | 400 E | 6.52 | 1.87 | -71.58% | -286 | 107 | |
20/04/11 | NICOX SA | Achat | 500 E | 5.52 | 1.84 | -67.07% | -335 | 1070 | |
20/04/11 | NICOX SA | Achat | 400 E | 7.27 | 1.83 | -75.08% | -300 | 317 | |
20/04/11 | NICOX SA | Achat | 500 E | 7.94 | 1.83 | -77.32% | -387 | 65 | |
20/04/11 | NICOX SA | Achat | 500 E | 6.16 | 1.83 | -70.68% | -353 | 113 | |
13/04/11 | INNATE PHARMA | Achat | 700 E | 2.01 | 1.35 | -33.17% | -232 | 271 | |
Enregistrements 851 à 900 sur 953 |